Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Sujit Rajagopalan is active.

Publication


Featured researches published by Sujit Rajagopalan.


Interactive Cardiovascular and Thoracic Surgery | 2013

Preoperative statin therapy is associated with lower requirement of renal replacement therapy in patients undergoing cardiac surgery: a meta-analysis of observational studies

Inderjeet Singh; Sujit Rajagopalan; Anand Srinivasan; Shyambalaji Achuthan; Puneet Dhamija; Debasish Hota; Amitava Chakrabarti

OBJECTIVES Acute kidney injury (AKI) following cardiac surgery is a common complication associated with serious morbidity and mortality. Activation of inflammatory cascade and vascular endothelial dysfunction plays a vital role during the perioperative period leading to AKI. Statins are known to suppress inflammation and improve endothelial dysfunction over and above the cholesterol lowering efficacy. METHODS Observational studies with a defined population in terms of preoperative statin therapy and no preoperative statin therapy undergoing cardiac surgery (CABG, isolated valve surgery or both) and with reported data on the incidence of acute renal failure/injury and/or mortality were identified and analysed for inclusion in the analysis. Outcomes evaluated were occurrence of postoperative acute kidney injury/failure, requirement of any postoperative renal replacement therapy and short-term all-cause mortality rate. A meta-analysis was conducted and a pooled estimate of odds ratio (OR) was calculated using the inverse variance method. RESULTS A total of 17 studies with a total population of 24 998 statin users and 22 082 non-statin users were included in the final analysis. PST resulted in a significantly lower incidence of renal replacement therapy in patients undergoing CABG (OR: 0.56 [0.41-0.76]) but not in isolated valve surgery (OR: 1.80 [0.73-4.44]). Also preoperative statin therapy resulted in a significantly lower postoperative mortality (0.72 [0.61-0.84]) irrespective of the type of surgery. There was no effect of preoperative statin therapy on the incidence of AKI in any of the sub-group of the patients. CONCLUSIONS Patients undergoing CABG might derive benefit from preoperative statin therapy in terms of reducing the need for postoperative renal replacement therapy and mortality. However, the uncertainty concerning the reno-protective efficacy of preoperative statin therapy in patients undergoing isolated valve surgery needs further investigation.


Evidence-based Medicine | 2012

Thiazolidinediones for plaque psoriasis: a systematic review and meta-analysis

Anita Malhotra; Nusrat Shafiq; Sujit Rajagopalan; Sunil Dogra; Samir Malhotra

Background There is some evidence for the role of inflammation and insulin resistance in the pathophysiology of plaque psoriasis. Thiazolidinediones are antidiabetic drugs that act by improving insulin sensitivity and also possess anti-inflammatory effects. Evidence from in vitro, animal and human studies has accumulated suggesting that these drugs may be of use in psoriasis. Objective This systematic review and meta-analysis was performed to assess the efficacy of thiazolidinediones on psoriasis severity. Study selection Randomised, open-label or single blind or double blind, published as well as unpublished, studies of thiazolidinedione administration compared with placebo, given to patients with plaque psoriasis for at least 8 weeks were considered for inclusion in this review. The primary outcomes were as follows: mean or mean percent change in Psoriasis Area and Severity Index (PASI) from baseline to end of treatment with pioglitazone, proportion of patients showing >75% improvement in PASI score, and proportion of patients showing >50% improvement in PASI score. Data analysis was done using Revman 5. Findings Twenty-seven relevant citations were identified. Two studies each for pioglitazone and rosiglitazone were included in the meta-analysis. There was a significantly greater mean decrease in PASI scores from baseline to end of treatment (−4.24 (95% CI −5.35 to −3.12)) in the pioglitazone group as compared to placebo. There was a non-significant improvement in PASI50/70 in the pooled analysis of rosiglitazone trials. Conclusion Pioglitazone appears to have efficacy for the treatment of psoriasis. The clinical significance of the effect and role in management of psoriasis deserve further study.


Pharmacoepidemiology and Drug Safety | 2015

Influence of pre-operative use of serotonergic antidepressants (SADs) on the risk of bleeding in patients undergoing different surgical interventions: a meta-analysis.

Inderjeet Singh; Shyambalaji Achuthan; Amitava Chakrabarti; Sujit Rajagopalan; Anand Srinivasan; Debasish Hota

Serotonergic antidepressants (SADs) are one of the most widely prescribed group of drugs. Of late, the use of SADs is being associated with an increased risk of perioperative bleeding. However, the results are inconsistent. The present analysis was planned to evaluate the association between preoperative SADs use and the risk of bleeding/mortality in patients undergoing surgery.


Diabetes Research and Clinical Practice | 2015

Effect of low dose pioglitazone on glycemic control and insulin resistance in Type 2 diabetes: A randomized, double blind, clinical trial

Sujit Rajagopalan; Pinaki Dutta; Debasish Hota; Anil Bhansali; Anand Srinivasan; Amitava Chakrabarti

This study shows that pioglitazone 7.5 mg/day as an add-on therapy in Southeast Asian patients with Type 2 diabetes is safer and equally efficacious as the 15- and 30-mg doses of pioglitazone. Hence it is prudent to start pioglitazone therapy at a lower dose of 7.5 mg/day.


Emergency Medicine International | 2014

Drug Utilization Study in Medical Emergency Unit of a Tertiary Care Hospital in North India

Sharonjeet Kaur; Sujit Rajagopalan; Navjot Kaur; Nusrat Shafiq; Ashish Bhalla; Promila Pandhi; Samir Malhotra

Objective. To generate data on the drug utilization pattern and cost of drug treatment and to determine the rationality of prescriptions. Methods. A retrospective cross-sectional drug utilization study was conducted in the medical emergency unit of our hospital. Patient case records were reviewed to extract data on the pattern of drug use. Cost of drug treatment for the emergency visit was calculated by referring to the cost mentioned in Monthly Index of Medical Specialties and the rationality of prescriptions was evaluated using WHO core indicators of drug utilization. Results. 1100 case records were reviewed. Majority of patients received proton pump inhibitors followed by multivitamins. The median cost per prescription was 119.23


Fundamental & Clinical Pharmacology | 2013

Effect of levofloxacin on lithium – a pharmacokinetic study in rabbits

Sujit Rajagopalan; Nusrat Shafiq; Promila Pandhi; Samir Malhotra

(7.32


Indian Journal of Pharmacology | 2012

Toxic Epidermal Necrolysis induced by rarely implicated drugs.

Sujit Rajagopalan; Sharonjeet Kaur; Sunil Dogra; Nusrat Shafiq; Ashish Bhalla; Promila Pandhi; Samir Malhotra

–7663.46


Contemporary Clinical Trials | 2011

Development of tool for the assessment of comprehension of informed consent form in healthy volunteers participating in first-in-human studies

Anjuman Arora; Sujit Rajagopalan; Nusrat Shafiq; Promila Pandhi; Ashish Bhalla; Deba Prasad Dhibar; Samir Malhotra

). Majority (49.9%) of drug cost was driven by antibiotics alone. An average of 4.9 drugs was prescribed per prescription. There were 14.89% encounters with antibiotics. 75.17% of the drugs were given as injectables and only 29.27% of the drugs were prescribed as generics. Conclusion. There is need to rationalize the drug therapy in terms of increasing prescribing of drugs by generic name and to avoid overuse of PPIs and multivitamins in emergency unit. Also the hospital pharmacy should be encouraged to procure more cost effective alternative antibiotics in future.


British Journal of Clinical Pharmacology | 2011

Pharmacotherapy of heart failure with normal ejection fraction (HFNEF) - a systematic review

Sujit Rajagopalan; Anjuman Arora; Nusrat Shafiq; Srinivas Reddy S; Promila Pandhi; Niti Mittal; Samir Malhotra

The aim of this study was to evaluate potential drug–drug interaction between lithium and levofloxacin. The study was conducted on New Zealand white rabbits with three groups having two subgroups each (n = 12). The first group compared the pharmacokinetic (Pk) parameters of lithium when lithium was given as a single dose (56 mg/kg) and when lithium was co‐administered with levofloxacin (35 mg/kg). The second group compared the Pk parameters of lithium when lithium was given for 6 days alone and when levofloxacin was given on the sixth day after lithium steady‐state levels were achieved. The third group compared the Pk parameters of lithium when lithium was given alone for 8 days and levofloxacin was given on days 6, 7, and 8 along with lithium. Apart from this, creatinine levels were also measured to detect nephrotoxicity effects because of this co‐administration. It was found that there was increase in lithium levels in all three groups. The increase was significant when a single dose of levofloxacin was administered with steady‐state level of lithium (Cmax of lithium: 2.54 ± 0.15 vs 2.79 ± 0.12 mm, P < 0.001 and AUC0‐α of lithium: 24.36 ± 3.68 vs 31.88 ± 4.83 mmol/mL h, P < 0.001). The increase in lithium levels was also significant when levofloxacin was coprescribed for 3 days after lithium steady‐state levels were achieved (Cmax increased from 2.72 ± 0.29 to 3.96 ± 0.29 mm, P < 0.001 and AUC0‐α increased from 27.1 ± 4.96 to 42.64 ± 4.94 mmol/mL h). Levofloxacin increases lithium levels when they are co‐administered, and this interaction might be clinically significant as they may be coprescribed.


Indian Journal of Dermatology, Venereology and Leprology | 2018

18F-fluorodeoxyglucose positron emission tomography-based evaluation of systemic and vascular inflammation and assessment of the effect of systemic treatment on inflammation in patients with moderate-to-severe psoriasis: A randomized placebo-controlled pilot study

Samir Malhotra; Sharonjeet Kaur; Nusrat Shafiq; Sunil Dogra; Bhagwant Rai Mittal; SavitaVerma Attri; Ajay Bahl; Tarun Narang; Keshavamurthy Vinay; Sujit Rajagopalan

Toxic Epidermal Necrolysis (TEN) and Steven-Johnson Syndrome (SJS) are serious disorders commonly caused as idiosyncratic reactions to drugs, the most common ones being oxicams, anticonvulsants, allopurinol, and sulfonamides. We present a case of TEN in a patient who developed the lesions after ingesting multiple drugs including paracetamol, metoclopramide, antihistamines, and multivitamins. These drugs have rarely been implicated in this disorder. The suspected drugs in this case were paracetamol and metoclopramide. However, the role of other drugs could not be ruled out definitely. The patient was managed with antibiotics, corticosteroids, and parenteral fluids and recovered well.

Collaboration


Dive into the Sujit Rajagopalan's collaboration.

Top Co-Authors

Avatar

Nusrat Shafiq

Post Graduate Institute of Medical Education and Research

View shared research outputs
Top Co-Authors

Avatar

Samir Malhotra

Post Graduate Institute of Medical Education and Research

View shared research outputs
Top Co-Authors

Avatar

Promila Pandhi

Post Graduate Institute of Medical Education and Research

View shared research outputs
Top Co-Authors

Avatar

Sharonjeet Kaur

Post Graduate Institute of Medical Education and Research

View shared research outputs
Top Co-Authors

Avatar

Sunil Dogra

Post Graduate Institute of Medical Education and Research

View shared research outputs
Top Co-Authors

Avatar

Anand Srinivasan

Post Graduate Institute of Medical Education and Research

View shared research outputs
Top Co-Authors

Avatar

Amitava Chakrabarti

Post Graduate Institute of Medical Education and Research

View shared research outputs
Top Co-Authors

Avatar

Ashish Bhalla

Post Graduate Institute of Medical Education and Research

View shared research outputs
Top Co-Authors

Avatar

Anjuman Arora

Post Graduate Institute of Medical Education and Research

View shared research outputs
Researchain Logo
Decentralizing Knowledge